Market Overview:
The global Kaposi sarcoma diagnosis market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Kaposi sarcoma, rising awareness about the disease, and technological advancements in diagnostic methods. Based on type, the global Kaposi sarcoma diagnosis market can be segmented into biopsy and imaging. The biopsy segment is expected to account for a larger share of the market than the imaging segment during the forecast period. This can be attributed to factors such as increasing demand for minimally invasive procedures and growing use of molecular diagnostics techniques for detecting early-stage tumors. Based on application, the global Kaposi sarcoma diagnosis market can be divided into hospitals, diagnostic centers, clinics, and others (including research institutes and academic medical centers).
Product Definition:
A Kaposi sarcoma diagnosis is made when a doctor finds cancer cells in tissue from the tumor. This type of cancer most often affects the skin, but it can also affect other parts of the body, such as lymph nodes, lungs, or digestive tract.
Biopsy:
A biopsy is a diagnostic procedure that involves the removal of tissue from a body part for examination under the microscope. Biopsies are most commonly used to diagnose cancer and other diseases but can also be used to examine skin lesions, inflammation, and infections.
The process of obtaining tissue samples by drilling small holes in the skin is known as core needle biopsy or surgical biopsy and is usually performed by medical practitioners such as GPs or dermatologists.
Imaging:
Imaging is a procedure where the internal body organs are examined by using X-rays, ultrasound or CT scans. The most common types of imaging procedures include chest imaging, abdominal/thoracic imaging and back/spine imaging.
Application Insights:
The market is segmented into hospital, diagnostic centers, clinics and others. The hospital segment dominated the overall application market in 2017 owing to the rising incidence of cancer worldwide. Increasing number of research initiatives by government and private organizations to improve diagnosis rate for kaposi sarcoma is also a key factor driving this segment. For instance, in June 2018 Indian Government¢â‚¬â„¢s National Cancer Center Japan (NCCJ) announced about establishing ¢â‚¬Å“Cancer Diagnosis Centre India (CDCI) with an investment of USD 12 million from NCCJ Global Grants for providing advanced diagnosis services for patients suffering from various cancers including lung, breast and colorectal cancer¢â‚¬. Such initiatives are expected to drive the market over next few years.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing government funding are some of the major factors contributing to its growth. For instance, in August 2018, Research!Health awarded a research grant for kaposiform sarcoma research (grant number R01GM079474). The researchers are looking into various aspects of sarcoma formation as well as signaling pathways involved in cancer development and progression.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to an increase in disposable income levels coupled with rising awareness about early diagnosis among patients & their families resulting in high demand for Kaposi Sarcoma Diagnosis Products & Services. In addition, growing medical tourism industry due to low treatment cost is also anticipated to boost regional growth over the forecast period.
Growth Factors:
- Increasing incidence of Kaposi sarcoma
- Rising awareness about Kaposi sarcoma and its symptoms
- Growing number of research and development activities for the treatment of Kaposi sarcoma
- Technological advancements in diagnosis and treatment of Kaposi sarcoma 5. increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Kaposi Sarcoma Diagnosis Market Research Report
By Type
Biopsy, Imaging
By Application
Hospital, Diagnostic centers, Clinics, Others
By Companies
Navidea Biopharmaceuticals, Inc, Quest Diagnostics, Cleveland Clinic, LightDeck Diagnostics, Mayo Foundation for Medical Education and Research (MFMER), Massachusetts General Hospital, UCLA Health, The Johns Hopkins Hospital, NYU Langone Hospitals, The Ohio State University Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Kaposi Sarcoma Diagnosis Market Report Segments:
The global Kaposi Sarcoma Diagnosis market is segmented on the basis of:
Types
Biopsy, Imaging
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Diagnostic centers, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Navidea Biopharmaceuticals, Inc
- Quest Diagnostics
- Cleveland Clinic
- LightDeck Diagnostics
- Mayo Foundation for Medical Education and Research (MFMER)
- Massachusetts General Hospital
- UCLA Health
- The Johns Hopkins Hospital
- NYU Langone Hospitals
- The Ohio State University Comprehensive Cancer Center
- Memorial Sloan Kettering Cancer Center
Highlights of The Kaposi Sarcoma Diagnosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biopsy
- Imaging
- By Application:
- Hospital
- Diagnostic centers
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Kaposi Sarcoma Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Kaposi sarcoma is a cancer that affects the skin and lymph nodes. It's most commonly found on the face, neck, chest, or limbs.
Some of the major players in the kaposi sarcoma diagnosis market are Navidea Biopharmaceuticals, Inc, Quest Diagnostics, Cleveland Clinic, LightDeck Diagnostics, Mayo Foundation for Medical Education and Research (MFMER), Massachusetts General Hospital, UCLA Health, The Johns Hopkins Hospital, NYU Langone Hospitals, The Ohio State University Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center.
The kaposi sarcoma diagnosis market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Kaposi Sarcoma Diagnosis Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Kaposi Sarcoma Diagnosis Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Kaposi Sarcoma Diagnosis Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Kaposi Sarcoma Diagnosis Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Kaposi Sarcoma Diagnosis Market Size & Forecast, 2018-2028 4.5.1 Kaposi Sarcoma Diagnosis Market Size and Y-o-Y Growth 4.5.2 Kaposi Sarcoma Diagnosis Market Absolute $ Opportunity
Chapter 5 Global Kaposi Sarcoma Diagnosis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Kaposi Sarcoma Diagnosis Market Size Forecast by Type
5.2.1 Biopsy
5.2.2 Imaging
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Kaposi Sarcoma Diagnosis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Kaposi Sarcoma Diagnosis Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Diagnostic centers
6.2.3 Clinics
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Kaposi Sarcoma Diagnosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Kaposi Sarcoma Diagnosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Kaposi Sarcoma Diagnosis Analysis and Forecast
9.1 Introduction
9.2 North America Kaposi Sarcoma Diagnosis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Kaposi Sarcoma Diagnosis Market Size Forecast by Type
9.6.1 Biopsy
9.6.2 Imaging
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Kaposi Sarcoma Diagnosis Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Diagnostic centers
9.10.3 Clinics
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Kaposi Sarcoma Diagnosis Analysis and Forecast
10.1 Introduction
10.2 Europe Kaposi Sarcoma Diagnosis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Kaposi Sarcoma Diagnosis Market Size Forecast by Type
10.6.1 Biopsy
10.6.2 Imaging
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Kaposi Sarcoma Diagnosis Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Diagnostic centers
10.10.3 Clinics
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Kaposi Sarcoma Diagnosis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Kaposi Sarcoma Diagnosis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Kaposi Sarcoma Diagnosis Market Size Forecast by Type
11.6.1 Biopsy
11.6.2 Imaging
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Kaposi Sarcoma Diagnosis Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Diagnostic centers
11.10.3 Clinics
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Kaposi Sarcoma Diagnosis Analysis and Forecast
12.1 Introduction
12.2 Latin America Kaposi Sarcoma Diagnosis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Kaposi Sarcoma Diagnosis Market Size Forecast by Type
12.6.1 Biopsy
12.6.2 Imaging
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Kaposi Sarcoma Diagnosis Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Diagnostic centers
12.10.3 Clinics
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Kaposi Sarcoma Diagnosis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Kaposi Sarcoma Diagnosis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Kaposi Sarcoma Diagnosis Market Size Forecast by Type
13.6.1 Biopsy
13.6.2 Imaging
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Kaposi Sarcoma Diagnosis Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Diagnostic centers
13.10.3 Clinics
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Kaposi Sarcoma Diagnosis Market: Competitive Dashboard
14.2 Global Kaposi Sarcoma Diagnosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Navidea Biopharmaceuticals, Inc
14.3.2 Quest Diagnostics
14.3.3 Cleveland Clinic
14.3.4 LightDeck Diagnostics
14.3.5 Mayo Foundation for Medical Education and Research (MFMER)
14.3.6 Massachusetts General Hospital
14.3.7 UCLA Health
14.3.8 The Johns Hopkins Hospital
14.3.9 NYU Langone Hospitals
14.3.10 The Ohio State University Comprehensive Cancer Center
14.3.11 Memorial Sloan Kettering Cancer Center